226 related articles for article (PubMed ID: 23922949)
1. MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts.
Curcio A; Torella D; Iaconetti C; Pasceri E; Sabatino J; Sorrentino S; Giampà S; Micieli M; Polimeni A; Henning BJ; Leone A; Catalucci D; Ellison GM; Condorelli G; Indolfi C
PLoS One; 2013; 8(7):e70158. PubMed ID: 23922949
[TBL] [Abstract][Full Text] [Related]
2. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
Zhou N; Ma B; Stoll S; Hays TT; Qiu H
Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
[TBL] [Abstract][Full Text] [Related]
3. Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in Connexin 43 and arrhythmogenesis.
Basheer WA; Harris BS; Mentrup HL; Abreha M; Thames EL; Lea JB; Swing DA; Copeland NG; Jenkins NA; Price RL; Matesic LE
J Mol Cell Cardiol; 2015 Nov; 88():1-13. PubMed ID: 26386426
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats.
Chen HJ; Yao L; Chen TG; Yu M; Wang LH; Chen JZ
Chin Med J (Engl); 2007 Nov; 120(21):1902-7. PubMed ID: 18067764
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of connexin43 by microRNA-130a in cardiomyocytes results in cardiac arrhythmias.
Osbourne A; Calway T; Broman M; McSharry S; Earley J; Kim GH
J Mol Cell Cardiol; 2014 Sep; 74():53-63. PubMed ID: 24819345
[TBL] [Abstract][Full Text] [Related]
7. Changes in Cx43 and NaV1.5 expression precede the occurrence of substantial fibrosis in calcineurin-induced murine cardiac hypertrophy.
Fontes MS; Raaijmakers AJ; van Doorn T; Kok B; Nieuwenhuis S; van der Nagel R; Vos MA; de Boer TP; van Rijen HV; Bierhuizen MF
PLoS One; 2014; 9(1):e87226. PubMed ID: 24498049
[TBL] [Abstract][Full Text] [Related]
8. GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function.
Fu YL; Tao L; Peng FH; Zheng NZ; Lin Q; Cai SY; Wang Q
Acta Pharmacol Sin; 2021 Apr; 42(4):536-549. PubMed ID: 32620936
[TBL] [Abstract][Full Text] [Related]
9. CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload.
Fontes MS; Kessler EL; van Stuijvenberg L; Brans MA; Falke LL; Kok B; Leask A; van Rijen HV; Vos MA; Goldschmeding R; van Veen TA
J Mol Cell Cardiol; 2015 Nov; 88():82-90. PubMed ID: 26410398
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-206 Downregulates Connexin43 in Cardiomyocytes to Induce Cardiac Arrhythmias in a Transgenic Mouse Model.
Jin Y; Zhou TY; Cao JN; Feng QT; Fu YJ; Xu X; Yang CJ
Heart Lung Circ; 2019 Nov; 28(11):1755-1761. PubMed ID: 30322759
[TBL] [Abstract][Full Text] [Related]
11. Newly Identified NO-Sensor Guanylyl Cyclase/Connexin 43 Association Is Involved in Cardiac Electrical Function.
Crassous PA; Shu P; Huang C; Gordan R; Brouckaert P; Lampe PD; Xie LH; Beuve A
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29269353
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling.
Karakikes I; Chaanine AH; Kang S; Mukete BN; Jeong D; Zhang S; Hajjar RJ; Lebeche D
J Am Heart Assoc; 2013 Apr; 2(2):e000078. PubMed ID: 23612897
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target.
Zhang ZH; Li J; Liu BR; Luo CF; Dong Q; Zhao LN; Zhong Y; Chen WY; Chen MS; Liu SM
J Cardiovasc Pharmacol; 2013 Sep; 62(3):312-9. PubMed ID: 23719092
[TBL] [Abstract][Full Text] [Related]
15. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
[TBL] [Abstract][Full Text] [Related]
16. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival.
Yang Y; Del Re DP; Nakano N; Sciarretta S; Zhai P; Park J; Sayed D; Shirakabe A; Matsushima S; Park Y; Tian B; Abdellatif M; Sadoshima J
Circ Res; 2015 Oct; 117(10):891-904. PubMed ID: 26333362
[TBL] [Abstract][Full Text] [Related]
17. Losartan reduced connexin43 expression in left ventricular myocardium of spontaneously hypertensive rats.
Zhao LL; Chen HJ; Chen JZ; Yu M; Ni YL; Zhang WF
J Zhejiang Univ Sci B; 2008 Jun; 9(6):448-54. PubMed ID: 18543397
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II-induced sudden arrhythmic death and electrical remodeling.
Fischer R; Dechend R; Gapelyuk A; Shagdarsuren E; Gruner K; Gruner A; Gratze P; Qadri F; Wellner M; Fiebeler A; Dietz R; Luft FC; Muller DN; Schirdewan A
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1242-53. PubMed ID: 17416596
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
[TBL] [Abstract][Full Text] [Related]
20. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
